Alex Porter

  • Commercialization Manager
  • Technology Commercialization & Licensing Team

Alex joined the Office of Technology Commercialization (OTC) in June 2017 and is responsible for commercialization of life sciences technologies, particular in the areas of pharmaceuticals and diagnostic assays. Prior to joining the OTC, Alex gained 5+ years of experience in supporting the competitive intelligence research needs of Top 10 big pharma and biotech companies at Sedulo Group, LLC in Louisville, Kentucky. Alex has extensive experience in monitoring drug development in therapeutic areas spanning multiple solid tumors and hematologic oncology indications as well as in cardiovascular and thoracic medicine. Alex is excited to bring his knowledge of the pharmaceutical and biotech sectors to OTC. Prior to joining Sedulo Group, Alex attended the University of Louisville, where he completed a Ph.D. in physiology and biophysics. His research focus involved the effects of VEGF on endothelial cell processes in an in vitro biomimetic environment. During his time there, he was privileged to also serve as an intern in the UofL Office of Technology Transfer for two years while still conducting research for his dissertation. He received a Bachelor of Science in biology from the University of Southern Indiana.